statistics 25 pearsons chi-square test software Search Results


exact pearson chi-square test  (Cytel Software)
90
Cytel Software exact pearson chi-square test
Exact Pearson Chi Square Test, supplied by Cytel Software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistics+25+pearsons+chi-square+test+software/exact+pearson+chi+square+test/pmc03119815-93-18-24
Average 90 stars, based on 1 article reviews
exact pearson chi-square test - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
pearson chi-square test  (MedCalc Software Ltd)
90
MedCalc Software Ltd pearson chi-square test
Pearson Chi Square Test, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistics+25+pearsons+chi-square+test+software/pearson+chi+square+test/pm28055379-24-11-21
Average 90 stars, based on 1 article reviews
pearson chi-square test - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
pearson’s chi-square test  (MedCalc Software Ltd)
90
MedCalc Software Ltd pearson’s chi-square test
POC for the effect of MPP on distinction between subjects. a Intergroup differences in the plasma Aβ concentration with or without 4% MPP solution using xMAP technology. MCI+ and ADD+ subjects show significantly decreased levels of MPP-Aβ42 and MPP-Aβ42/40 ratio compared with CN– subjects (** P < 0.01 and *** P < 0.001 respectively; ANOVA followed by Tukey’s multiple comparison test; CN–, n = 20; MCI+, n = 12; ADD+, n = 23; total subjects, n = 55). b Correlation of global PiB deposition (SUVR) and MPP-Aβs. MPP-Aβ42 level (*** P < 0.001, r = –0.47; <t>Pearson’s</t> correlation) and MPP-Aβ42/40 ratio (** P < 0.01, r = –0.39; Pearson’s correlation) are correlated with global PiB deposition (SUVR). Aβ β-amyloid, MPP mixture of protease inhibitors and phosphatase inhibitors, MCI mild cognitive impairment, ADD Alzheimer’s disease dementia, CN cognitively normal, SUVR standard uptake value ratio, PiB Pittsburgh compound B, – or + PiB negativity or positivity
Pearson’s Chi Square Test, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistics+25+pearsons+chi-square+test+software/pearson%E2%80%99s+chi+square+test/pmc05361707-131-0-24
Average 90 stars, based on 1 article reviews
pearson’s chi-square test - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
exact pearson chi-square test statxact v6.0  (Cytel Software)
90
Cytel Software exact pearson chi-square test statxact v6.0
POC for the effect of MPP on distinction between subjects. a Intergroup differences in the plasma Aβ concentration with or without 4% MPP solution using xMAP technology. MCI+ and ADD+ subjects show significantly decreased levels of MPP-Aβ42 and MPP-Aβ42/40 ratio compared with CN– subjects (** P < 0.01 and *** P < 0.001 respectively; ANOVA followed by Tukey’s multiple comparison test; CN–, n = 20; MCI+, n = 12; ADD+, n = 23; total subjects, n = 55). b Correlation of global PiB deposition (SUVR) and MPP-Aβs. MPP-Aβ42 level (*** P < 0.001, r = –0.47; <t>Pearson’s</t> correlation) and MPP-Aβ42/40 ratio (** P < 0.01, r = –0.39; Pearson’s correlation) are correlated with global PiB deposition (SUVR). Aβ β-amyloid, MPP mixture of protease inhibitors and phosphatase inhibitors, MCI mild cognitive impairment, ADD Alzheimer’s disease dementia, CN cognitively normal, SUVR standard uptake value ratio, PiB Pittsburgh compound B, – or + PiB negativity or positivity
Exact Pearson Chi Square Test Statxact V6.0, supplied by Cytel Software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistics+25+pearsons+chi-square+test+software/exact+pearson+chi+square+test+statxact+v6+0/pmc03119815-133-20-22
Average 90 stars, based on 1 article reviews
exact pearson chi-square test statxact v6.0 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
pearson exact chi-square goodness of fit test  (Cytel Software)
90
Cytel Software pearson exact chi-square goodness of fit test
POC for the effect of MPP on distinction between subjects. a Intergroup differences in the plasma Aβ concentration with or without 4% MPP solution using xMAP technology. MCI+ and ADD+ subjects show significantly decreased levels of MPP-Aβ42 and MPP-Aβ42/40 ratio compared with CN– subjects (** P < 0.01 and *** P < 0.001 respectively; ANOVA followed by Tukey’s multiple comparison test; CN–, n = 20; MCI+, n = 12; ADD+, n = 23; total subjects, n = 55). b Correlation of global PiB deposition (SUVR) and MPP-Aβs. MPP-Aβ42 level (*** P < 0.001, r = –0.47; <t>Pearson’s</t> correlation) and MPP-Aβ42/40 ratio (** P < 0.01, r = –0.39; Pearson’s correlation) are correlated with global PiB deposition (SUVR). Aβ β-amyloid, MPP mixture of protease inhibitors and phosphatase inhibitors, MCI mild cognitive impairment, ADD Alzheimer’s disease dementia, CN cognitively normal, SUVR standard uptake value ratio, PiB Pittsburgh compound B, – or + PiB negativity or positivity
Pearson Exact Chi Square Goodness Of Fit Test, supplied by Cytel Software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistics+25+pearsons+chi-square+test+software/pearson+exact+chi+square+goodness+of+fit+test/10__1080_slash_07060661__2016__1263807-120-25-27
Average 90 stars, based on 1 article reviews
pearson exact chi-square goodness of fit test - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


POC for the effect of MPP on distinction between subjects. a Intergroup differences in the plasma Aβ concentration with or without 4% MPP solution using xMAP technology. MCI+ and ADD+ subjects show significantly decreased levels of MPP-Aβ42 and MPP-Aβ42/40 ratio compared with CN– subjects (** P < 0.01 and *** P < 0.001 respectively; ANOVA followed by Tukey’s multiple comparison test; CN–, n = 20; MCI+, n = 12; ADD+, n = 23; total subjects, n = 55). b Correlation of global PiB deposition (SUVR) and MPP-Aβs. MPP-Aβ42 level (*** P < 0.001, r = –0.47; Pearson’s correlation) and MPP-Aβ42/40 ratio (** P < 0.01, r = –0.39; Pearson’s correlation) are correlated with global PiB deposition (SUVR). Aβ β-amyloid, MPP mixture of protease inhibitors and phosphatase inhibitors, MCI mild cognitive impairment, ADD Alzheimer’s disease dementia, CN cognitively normal, SUVR standard uptake value ratio, PiB Pittsburgh compound B, – or + PiB negativity or positivity

Journal: Alzheimer's Research & Therapy

Article Title: Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition

doi: 10.1186/s13195-017-0248-8

Figure Lengend Snippet: POC for the effect of MPP on distinction between subjects. a Intergroup differences in the plasma Aβ concentration with or without 4% MPP solution using xMAP technology. MCI+ and ADD+ subjects show significantly decreased levels of MPP-Aβ42 and MPP-Aβ42/40 ratio compared with CN– subjects (** P < 0.01 and *** P < 0.001 respectively; ANOVA followed by Tukey’s multiple comparison test; CN–, n = 20; MCI+, n = 12; ADD+, n = 23; total subjects, n = 55). b Correlation of global PiB deposition (SUVR) and MPP-Aβs. MPP-Aβ42 level (*** P < 0.001, r = –0.47; Pearson’s correlation) and MPP-Aβ42/40 ratio (** P < 0.01, r = –0.39; Pearson’s correlation) are correlated with global PiB deposition (SUVR). Aβ β-amyloid, MPP mixture of protease inhibitors and phosphatase inhibitors, MCI mild cognitive impairment, ADD Alzheimer’s disease dementia, CN cognitively normal, SUVR standard uptake value ratio, PiB Pittsburgh compound B, – or + PiB negativity or positivity

Article Snippet: Pearson’s chi-square test (χ 2 ) was carried out to evaluate the intergroup differences of two-category variables (gender, apolipoprotein E ε4 carrier status) using Medcalc software.

Techniques: Clinical Proteomics, Concentration Assay, Comparison

MPP-Aβs reflect the pathological load of Aβ in the brain. a Intergroup differences of MPP-Aβ levels using xMAP technology (* P < 0.05 and ** P < 0.01, unpaired t test; § P < 0.05, §§ P < 0.01, and §§§ P < 0.001, ANOVA followed by Tukey’s multiple comparison test; # P < 0.10, unpaired t test, trend toward significance; CN–, n = 187, CN+, n = 28, MCI–, n = 50, MCI+, n = 29, ADD–, n = 16, ADD+, n = 43; total subjects n = 353). b Correlation of global PiB deposition (SUVR) and MPP-Aβs ( n = 353, *** P < 0.0001; Pearson’s correlation). c , d MPP-Aβ42, MPP-Aβ40, and MPP-Aβ42/40 levels in ND– ( n = 237; CN– and MCI–), ND+ ( n = 57; CN+ and MCI+), PiB– ( n = 253; CN–, MCI–, and ADD–), and PiB+ ( n = 100; CN+, MCI+, and ADD+) (** P < 0.01, and *** P < 0.001, unpaired t test). Aβ β-amyloid, MPP mixture of protease inhibitors and phosphatase inhibitors, MCI mild cognitive impairment, ADD Alzheimer’s disease dementia, CN cognitively normal, SUVR standard uptake value ratio, PiB Pittsburgh compound B, – or + PiB negativity or positivity, ND nondemented

Journal: Alzheimer's Research & Therapy

Article Title: Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition

doi: 10.1186/s13195-017-0248-8

Figure Lengend Snippet: MPP-Aβs reflect the pathological load of Aβ in the brain. a Intergroup differences of MPP-Aβ levels using xMAP technology (* P < 0.05 and ** P < 0.01, unpaired t test; § P < 0.05, §§ P < 0.01, and §§§ P < 0.001, ANOVA followed by Tukey’s multiple comparison test; # P < 0.10, unpaired t test, trend toward significance; CN–, n = 187, CN+, n = 28, MCI–, n = 50, MCI+, n = 29, ADD–, n = 16, ADD+, n = 43; total subjects n = 353). b Correlation of global PiB deposition (SUVR) and MPP-Aβs ( n = 353, *** P < 0.0001; Pearson’s correlation). c , d MPP-Aβ42, MPP-Aβ40, and MPP-Aβ42/40 levels in ND– ( n = 237; CN– and MCI–), ND+ ( n = 57; CN+ and MCI+), PiB– ( n = 253; CN–, MCI–, and ADD–), and PiB+ ( n = 100; CN+, MCI+, and ADD+) (** P < 0.01, and *** P < 0.001, unpaired t test). Aβ β-amyloid, MPP mixture of protease inhibitors and phosphatase inhibitors, MCI mild cognitive impairment, ADD Alzheimer’s disease dementia, CN cognitively normal, SUVR standard uptake value ratio, PiB Pittsburgh compound B, – or + PiB negativity or positivity, ND nondemented

Article Snippet: Pearson’s chi-square test (χ 2 ) was carried out to evaluate the intergroup differences of two-category variables (gender, apolipoprotein E ε4 carrier status) using Medcalc software.

Techniques: Comparison